title: Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response.
authors.affiliation: Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Xiaochun
authors.initials: X
authors.lastname: Liu
authors.forename: Patricia
authors.initials: P
authors.lastname: Lorusso
authors.forename: Monica
authors.initials: M
authors.lastname: Mita
authors.forename: Sarina
authors.initials: S
authors.lastname: Piha-Paul
authors.forename: David S
authors.initials: DS
authors.lastname: Hong
authors.forename: Siqing
authors.initials: S
authors.lastname: Fu
authors.forename: Lacey
authors.initials: L
authors.lastname: McQuinn
authors.forename: Ekaterine
authors.initials: E
authors.lastname: Asatiani
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Doyle
authors.forename: Helen X
authors.initials: HX
authors.lastname: Chen
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: Hess
authors.forename: Razelle
authors.initials: R
authors.lastname: Kurzrock
authors.forename: Aung
authors.initials: A
authors.lastname: Naing
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D052016:Mucositis / Q000139:chemically induced / Q000453:epidemiology*; D009536:Niacinamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D020123:Sirolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C550600:N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide; D047428:Protein Kinase Inhibitors; C557414:cixutumumab; D009536:Niacinamide; C401859:temsirolimus; D008687:Metformin; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus